Concepedia

Antonio Pinto

AP

Statistics

Publications

127

Citations

6.9K

H-Index

44

Active since

1981

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Centro di Riferimento Oncologico

Istituti di Ricovero e Cura a Carattere Scientifico

University of Naples Federico II

Fondazione IRCCS Istituto Nazionale dei Tumori

Antonio Pinto is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, oncology, and life sciences.

ORCID

Publications per year

1981–2025

127

Publications

127

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

, , +16

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada et al. · Journal of Clinical Oncology · 2017 · 424 citations

, , +12

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

John P. Leonard, Marek Trněný, Koji Izutsu et al. · Journal of Clinical Oncology · 2019 · 421 citations · Full text

, , +15

Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines

Antonino Carbone, Annunziata Gloghini, Valter Gattei et al. · Blood · 1995 · 208 citations

, , +6

5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias

Antonio Pinto, Vincenza Attadia, A. Fusco et al. · Blood · 1984 · 172 citations · Full text

, , +11

1–5 of 127